van Vollenhoven RF - Search Results

1

Rheumatoid arthritis registries in Sweden.

van Vollenhoven RF, Askling J. van Vollenhoven RF, et al. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S195-200. Clin Exp Rheumatol. 2005. PMID: 16273807

2

Rheumatoid arthritis. Designing and implementing a treatment plan.

Gremillion RB, van Vollenhoven RF. Gremillion RB, et al. Among authors: van vollenhoven rf. Postgrad Med. 1998 Feb;103(2):103-6, 110, 116-8 passim. doi: 10.3810/pgm.1998.02.314. Postgrad Med. 1998. PMID: 9479310 Review.

3

Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.

Berg L, Lampa J, Rogberg S, van Vollenhoven R, Klareskog L. Berg L, et al. Ann Rheum Dis. 2001 Feb;60(2):133-9. doi: 10.1136/ard.60.2.133. Ann Rheum Dis. 2001. PMID: 11156546 Free PMC article.

4

[Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].

Larsson P, Bratt J, Harju A, van Vollenhoven R, Klareskog L. Larsson P, et al. Lakartidningen. 2001 Feb 21;98(8):828-31. Lakartidningen. 2001. PMID: 11265568 Review. Swedish.

5

Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.

Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH. Gunnarsson I, et al. J Rheumatol. 2002 Apr;29(4):693-9. J Rheumatol. 2002. PMID: 11950009

6

Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.

Kavanaugh A, Genovese M, Baughman J, Kivitz A, Bulpitt K, Olsen N, Weisman M, Matteson E, Furst D, van Vollenhoven R, Anderson J, Cohen S, Wei N, Meijerink J, Jacobs C, Mocci S. Kavanaugh A, et al. J Rheumatol. 2003 Mar;30(3):449-54. J Rheumatol. 2003. PMID: 12610799 Clinical Trial.

7

Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.

van Vollenhoven RF, Klareskog L. van Vollenhoven RF, et al. Arthritis Rheum. 2003 Jun;48(6):1500-3. doi: 10.1002/art.11027. Arthritis Rheum. 2003. PMID: 12794816 Free article.

8

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.

van Vollenhoven R, Harju A, Brannemark S, Klareskog L. van Vollenhoven R, et al. Ann Rheum Dis. 2003 Dec;62(12):1195-8. doi: 10.1136/ard.2003.009589. Ann Rheum Dis. 2003. PMID: 14644858 Free PMC article.

9

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.

van Vollenhoven RF, Ernestam S, Harju A, Bratt J, Klareskog L. van Vollenhoven RF, et al. Arthritis Res Ther. 2003;5(6):R347-51. doi: 10.1186/ar1005. Epub 2003 Oct 1. Arthritis Res Ther. 2003. PMID: 14680509 Free PMC article.

10

Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.

van Vollenhoven RF, Brannemark S, Klareskog L. van Vollenhoven RF, et al. Ann Rheum Dis. 2004 Apr;63(4):426-30. doi: 10.1136/ard.2003.010967. Ann Rheum Dis. 2004. PMID: 15020338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results